Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Cancer Cell|July 22, 2022
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancerYang Chen, Sujuan Yang, Jena Tavormina, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Targeted suppression of SPP1 inhibits tumor invasion and metastasis in NRF2 hyperactivated cisplatin resistant HNSCCMutsuki Kawabe, Sujuan Yang, Lorena Gomez Bolanos, et al.Biomaterials Advances|October 1, 2023
Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cellsDébora Ferreira, Cátia Santos-Pereira, Marta Costa, et al.Cancer Biology & Therapy|January 26, 2017
Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancerSujuan Yang, Sara P Y Che, Paul Kurywchak, et al.Journal of Translational Medicine|May 23, 2026
Targeted suppression of SPP1 inhibits tumor invasion and metastasis in NRF2 hyperactivated cisplatin resistant HNSCCMutsuki Kawabe, Sujuan Yang, Lorena I Gomez-Bolanos, et al.Cancer Discovery|March 29, 2022
Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic CancerKathleen M McAndrews, Yang Chen, J Kebbeh Darpolor, et al.JCI Insight|April 20, 2018
Generation and testing of clinical-grade exosomes for pancreatic cancerMayela Mendt, Sushrut Kamerkar, Hikaru Sugimoto, et al.Science Advances|October 29, 2020
Induced, but not natural, regulatory T cells retain phenotype and function following exposure to inflamed synovial fibroblastsSujuan Yang, Ximei Zhang, Jingrong Chen, et al.Biorxiv : the Preprint Server for Biology|February 24, 2023
Oncogenic Kras G12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 + T cells dependent mannerKrishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu, et al.Nature Communications|September 30, 2025
Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlatesValerie S Kalluri, Brandon G Smaglo, Krishnan K Mahadevan, et al.Pageof 4